-
Study aim
-
This randomized controlled trial aims to evaluate the anti-cholelithiasis activity of vinegar-soaked Ficus carica fruit in adults diagnosed with cholelithiasis.
-
Design
-
Pragmatic, community based, parallel group, single blinded, randomised controlled trial. Total 50 patients will be enrolled. Patients who met our inclusion criteria will be randomised into two groups. Treatment group-A and control group-B
-
Settings and conduct
-
At Noreen Nishat Welfare Hospital ,Khanewal ,Pakistan (ref no: 1015) after approval for the study design granted by the Review Board and the Ethical Committee of Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Participants in the study will be included who will be adults aged 18 to 50 years diagnosed with cholelithiasis, confirmed by a radiologist pediatrician through ultrasound testing and of both genders. Excluison criteria: The exclusion criteria included individuals with major systemic diseases, prior gallbladder surgery, gallstone medications, or pregnancy and lactating mothers
-
Intervention groups
-
Participants in the the control group-A will be given ursodiol 600 mg per day as the standard drug, and treatment group-B participants will be given VSFCF orally at a standard dose of 1g/kg/day for 3 months to assess the treatment’s effects. Both groups will be adhere to the same schedule and duration of administration for a comparative analysis of outcomes.
-
Main outcome variables
-
In the study, the primary outcome focus will be on evaluating changes in gallstone size that will be measured at the beginning and after 3 months of intervention. Additionally, secondary outcomes included analyzing the composition of gallstones to understand any structural changes.